Glimepiride
گلیمپیراید
🍽️ Alimentary Tract And MetabolismSulfonylurea
Market / country: 🇺🇸 USA
Amaryl (US)
🧮 Dose calculator
Type 2 diabetes mellitus · Regimen source: FDA Glimepiride · 2.1
- • Increase by 1 or 2 mg no more often than every 1–2 weeks; max 8 mg. Elderly or renal impairment: start 1 mg. FDA Glimepiride · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to glimepiride or sulfonamide derivatives. FDA Glimepiride · 4
Formulations
- 1 mg tablet (scored) — tablet 🇺🇸 USA FDA Glimepiride · 3
- 2 mg tablet (scored) — tablet 🇺🇸 USA FDA Glimepiride · 3
- 4 mg tablet (scored) — tablet 🇺🇸 USA FDA Glimepiride · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Glimepiride · 8.1
“Risk Summary Available data from a small number of published studies and postmarketing experience with glimepiride tablets use in pregnancy over decades have not identified any drug associated risks for major birth defects, miscarriage, or adverse maternal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Glimepiride · 8.2
“Risk Summary Breastfed infants of lactating women using glimepiride tablets should be monitored for symptoms of hypoglycemia (see Clinical Considerations) .”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Glimepiride · 8.4
“Glimepiride is not recommended in pediatric patients because of its adverse effects on body weight and hypoglycemia.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Glimepiride · 8.5
“In addition, hypoglycemia may be difficult to recognize in the elderly [ see Dosage and Administration ( 2.1 ) and Warnings and Precautions ( 5.1 ) ].”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA202112
- DailyMed (FDA label)FDA Glimepiride
- MedlinePlus (NIH)Glimepiride
- WHO ATC/DDDA10BB12
- Darooyab (Iran)Glimepiride
🇮🇷 Registered in Iran Darooyab · G-628/Glimepiride
Dosage forms with Iranian generic codes, per Darooyab.
- 07707 · GLIMEPIRID 1MG TAB · قرص گلیمپیرید ۱ میلیگرم
- 06456 · GLIMEPIRID 2MG TAB · قرص گلیمپیرید ۲ میلیگرم
- 07586 · GLIMEPIRID 4MG TAB · قرص گلیمپیرید ۴ میلیگرم
- 52425 · GLIMEPIRIDE TABLET ORAL 4 mg · قرص گلیمپیرید ۴ میلیگرم
- 52422 · GLIMEPIRIDE TABLET ORAL 1 mg · قرص گلیمپیرید ۱ میلیگرم
- 52423 · GLIMEPIRIDE TABLET ORAL 2 mg · قرص گلیمپیرید ۲ میلیگرم
- 52424 · GLIMEPIRIDE TABLET ORAL 3 mg · قرص گلیمپیرید ۳ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Glimepiride · 3FDA Glimepiride · 2.1FDA Glimepiride · 2FDA Glimepiride · 8.4FDA Glimepiride · 4FDA Glimepiride · 8.1FDA Glimepiride · 8.2FDA Glimepiride · 8.5FDA Glimepiride · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-628/Glimepiride
- Clinical review⚠ Unverified